Advertisement
U.S. markets close in 1 hour 41 minutes

  • S&P 500

    4,562.30
    -32.33 (-0.70%)
     

  • Dow 30

    36,172.67
    -72.83 (-0.20%)
     

  • Nasdaq

    14,147.22
    -157.81 (-1.10%)
     

  • Russell 2000

    1,874.52
    +11.88 (+0.64%)
     

  • Crude Oil

    73.25
    -0.82 (-1.11%)
     

  • Gold

    2,043.10
    -46.60 (-2.23%)
     

  • Silver

    24.87
    -0.99 (-3.82%)
     

  • EUR/USD

    1.0823
    -0.0062 (-0.57%)
     

  • 10-Yr Bond

    4.2900
    +0.0640 (+1.51%)
     

  • GBP/USD

    1.2612
    -0.0102 (-0.80%)
     

  • USD/JPY

    147.4160
    +0.6550 (+0.45%)
     

  • Bitcoin USD

    41,840.46
    +2,343.98 (+5.93%)
     

  • CMC Crypto 200

    859.62
    +0.91 (+0.11%)
     

  • FTSE 100

    7,512.96
    -16.39 (-0.22%)
     

  • Nikkei 225

    33,231.27
    -200.24 (-0.60%)
     

Alcon to pay Johnson & Johnson $199 million to settle eye-laser cases

Blake Brittain
·2 min read
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

By Blake Brittain

(Reuters) - Alcon Vision LLC will pay Johnson & Johnson's J&J Surgical Vision Inc $199 million to settle legal battles over intellectual property related to the companies' laser eye-surgery devices, Alcon said in a press release on Sunday.

Alcon said the one-time payment would resolve "various worldwide intellectual property disputes" and that the companies had reached a cross-licensing agreement.

Representatives for Johnson & Johnson did not immediately respond to a request for comment Monday on the settlement.

A copyright trial was set to begin this week in Delaware federal court over claims that Alcon stole software from J&J's iFS Laser system, used for LASIK vision correction and other surgeries, and utilized it in Alcon's LenSx system to treat cataracts. A J&J expert had argued that the company was entitled to at least $3.1 billion in damages.

Both companies also accused each other of patent infringement in claims that had been put on hold by the Delaware court.

New Brunswick, New Jersey-based J&J's Catalys laser cataract surgery system competes with LenSx.

AMO Development LLC, which J&J acquired in 2017, sued Alcon in 2020 for allegedly stealing thousands of lines of its source code. It accused Alcon in a 2021 court filing of committing "theft and deception on a grand and shocking scale - of the type usually found in paperback novels and Hollywood movies, not real-life disputes between publicly traded companies."

J&J said Alcon left "smoking guns" in its code that showed its theft, like typographical errors identical to those in J&J's code and comments dating from before LenSx development started.

U.S. District Judge Colm Connolly said during a 2021 hearing that there was "overwhelming" evidence that Alcon intentionally copied J&J's code.

Fort Worth, Texas-headquartered Alcon had denied the allegations.

The case is AMO Development LLC v. Alcon Vision LLC, U.S. District Court for the District of Delaware, No. 1:20-cv-00842

(Reporting by Blake Brittain in Washington)

Advertisement